PYXS
Pyxis Oncology Inc
2.90$
-2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +372.1% | -100.0% | – | – | -100.0% | – | -100.0% | – | -100.0% | – | – | |
| – | – | – | – | – | – | – | +0.6% | +24.2% | +21.8% | +6.7% | -8.5% | -28.0% | +109.3% | -3.1% | +12.7% | -37.7% | +23.2% | +25.0% | +132.7% | -67.5% | -3.1% | -100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +489.8% | -103.7% | – | – | -132.5% | – | -100.0% | – | -104.0% | – | – | |
| – | +0.0% | +39.2% | +29.4% | +944.1% | -90.2% | +144.9% | -7.9% | +177.8% | -14.5% | +10.9% | +56.8% | -60.1% | -4.3% | +28.9% | -21.0% | +12.3% | +7.1% | +27.1% | -21.0% | +21.5% | +0.5% | +3.9% | +21.9% | -9.7% | -18.1% | – | |
| – | +0.0% | -6.4% | +87.7% | +105.2% | -7.4% | +37.9% | +143.9% | +23.0% | -24.4% | +9.4% | -13.2% | +11.5% | -25.7% | +58.5% | -42.3% | +33.9% | -26.3% | -1.1% | -15.5% | +15.5% | -7.4% | +4.0% | -7.4% | -16.4% | +126.9% | – | |
| – | +0.0% | +24.6% | +43.5% | +680.3% | -83.4% | +95.6% | +41.3% | +91.1% | -18.0% | +10.4% | +33.7% | -44.8% | -13.5% | +39.9% | -29.9% | +19.8% | -5.8% | +18.6% | +68.7% | -42.8% | -1.5% | +3.9% | +26.9% | -19.7% | +8.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +50.0% | – | – | -100.0% | +1,722.2% | +338.4% | +8,104.0% | -97.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +98.9% | -41.4% | +1,551.6% | -100.0% | – | – | – | – | – | – | – | -72.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -184.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.